1,566 reports of this reaction
1.4% of all ACETAMINOPHEN AND CODEINE reports
#7 most reported adverse reaction
RHEUMATOID ARTHRITIS is the #7 most commonly reported adverse reaction for ACETAMINOPHEN AND CODEINE, manufactured by Amneal Pharmaceuticals LLC. There are 1,566 FDA adverse event reports linking ACETAMINOPHEN AND CODEINE to RHEUMATOID ARTHRITIS. This represents approximately 1.4% of all 113,152 adverse event reports for this drug.
Patients taking ACETAMINOPHEN AND CODEINE who experience rheumatoid arthritis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RHEUMATOID ARTHRITIS is a less commonly reported adverse event for ACETAMINOPHEN AND CODEINE, but still significant enough to appear in the safety profile.
In addition to rheumatoid arthritis, the following adverse reactions have been reported for ACETAMINOPHEN AND CODEINE:
The following drugs have also been linked to rheumatoid arthritis in FDA adverse event reports:
RHEUMATOID ARTHRITIS has been reported as an adverse event in 1,566 FDA reports for ACETAMINOPHEN AND CODEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RHEUMATOID ARTHRITIS accounts for approximately 1.4% of all adverse event reports for ACETAMINOPHEN AND CODEINE, making it a notable side effect.
If you experience rheumatoid arthritis while taking ACETAMINOPHEN AND CODEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.